SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kim Sinil

(Last)

(First)

(Middle)

C/O MIRNA THERAPEUTICS, INC.

2150 WOODWARD ST., SUITE 100

(Street)

AUSTIN

78744

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2015

3. Issuer Name and Ticker or Trading Symbol
Mirna Therapeutics, Inc. [ MIRN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
09/30/2015

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)⁽¹⁾	⁽²⁾	12/30/2023	Common Stock	9,062⁽¹⁾	$4.35	D
Stock Option (Right to Buy)⁽¹⁾	⁽³⁾	03/10/2024	Common Stock	14,566⁽¹⁾	$8.1	D

Explanation of Responses:

1. This Amendment is being filed solely to correct the balance of shares held by the reporting person with respect to the options restated herein. The aggregate total number of option shares held by the Reporting Person was correctly reported originally.

2. The option vests with respect to 25% of the shares subject thereto on March 6, 2014, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.

3. The option vests with respect to 25% of the shares subject thereto on March 10, 2015, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.

Remarks:

	/s/ Jon Irvin, Attorney-in-Fact for Sinil Kim	03/07/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.